Payer perceptions of fairness in pricing rare disease therapies

August 4, 2020

The debate over pricing of therapies often centers on the question of value and how best to determine it. In this RARE Daily RareCast podcast episode, Andy Parece and Matt Majewski take an interesting approach to understanding the way payers view the pricing of rare therapies. Instead of asking them about pricing in terms of value, they asked about it in terms of fairness.

In the episode, Parece and Majewski expand on how payers view the pricing of rare disease therapies, how context changes perceptions around pricing, and why they began questioning payers about the issue of fairness.

RARECast · Payer Perceptions of Fairness in Pricing Rare Disease Therapies